CONFLICT OF INTEREST
ONCOLOGY, VIDAL
Dr. Vidal reported receiving personal fees from Roche/Genentech, Novartis, Eli Lilly, Immunometric, Puma, Pfizer, AstraZeneca, Biotheranautics, Daiichi Sankyo, Vector Oncology and research funding from Roche/Genentech, Puma, Celcuity, Merck, BMS, Eli Lilly, GTx Inc., AstraZeneca, Pfizer, Immunomedics, Tesaro, Halozyme, and ownership of Oncodisc. Dr. Schwartzberg reported receiving personal fees from Amgen, Pfizer, Helsinn, Genentech, Genomic Health, BMS, Myriad, AstraZeneca, Bayer, Spectrum, Napo and research support from Amgen, Pfizer. Dr. Graetz received research support from Pfizer. Ms. Hu received a dissertation grant from PhRMA Foundation. No other disclosures were reported.